rs28571612

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_139027.6(ADAMTS13):​c.354G>A​(p.Pro118Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0725 in 1,613,360 control chromosomes in the GnomAD database, including 4,962 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.055 ( 321 hom., cov: 32)
Exomes 𝑓: 0.074 ( 4641 hom. )

Consequence

ADAMTS13
NM_139027.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -4.01

Publications

15 publications found
Variant links:
Genes affected
ADAMTS13 (HGNC:1366): (ADAM metallopeptidase with thrombospondin type 1 motif 13) This gene encodes a member of a family of proteins containing several distinct regions, including a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. The enzyme encoded by this gene specifically cleaves von Willebrand Factor (vWF). Defects in this gene are associated with thrombotic thrombocytopenic purpura. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
ADAMTS13 Gene-Disease associations (from GenCC):
  • congenital thrombotic thrombocytopenic purpura
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 9-133425552-G-A is Benign according to our data. Variant chr9-133425552-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.01 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0848 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADAMTS13NM_139027.6 linkc.354G>A p.Pro118Pro synonymous_variant Exon 4 of 29 ENST00000355699.7 NP_620596.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADAMTS13ENST00000355699.7 linkc.354G>A p.Pro118Pro synonymous_variant Exon 4 of 29 1 NM_139027.6 ENSP00000347927.2

Frequencies

GnomAD3 genomes
AF:
0.0549
AC:
8357
AN:
152140
Hom.:
321
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0152
Gnomad AMI
AF:
0.0285
Gnomad AMR
AF:
0.0476
Gnomad ASJ
AF:
0.0711
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0199
Gnomad FIN
AF:
0.0560
Gnomad MID
AF:
0.0573
Gnomad NFE
AF:
0.0867
Gnomad OTH
AF:
0.0585
GnomAD2 exomes
AF:
0.0568
AC:
14169
AN:
249508
AF XY:
0.0572
show subpopulations
Gnomad AFR exome
AF:
0.0146
Gnomad AMR exome
AF:
0.0328
Gnomad ASJ exome
AF:
0.0692
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0568
Gnomad NFE exome
AF:
0.0879
Gnomad OTH exome
AF:
0.0636
GnomAD4 exome
AF:
0.0743
AC:
108616
AN:
1461102
Hom.:
4641
Cov.:
32
AF XY:
0.0726
AC XY:
52734
AN XY:
726838
show subpopulations
African (AFR)
AF:
0.0122
AC:
409
AN:
33480
American (AMR)
AF:
0.0342
AC:
1530
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.0678
AC:
1772
AN:
26128
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39696
South Asian (SAS)
AF:
0.0203
AC:
1746
AN:
86198
European-Finnish (FIN)
AF:
0.0566
AC:
2996
AN:
52968
Middle Eastern (MID)
AF:
0.0563
AC:
324
AN:
5760
European-Non Finnish (NFE)
AF:
0.0862
AC:
95855
AN:
1111800
Other (OTH)
AF:
0.0659
AC:
3981
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
5233
10466
15699
20932
26165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3406
6812
10218
13624
17030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0549
AC:
8356
AN:
152258
Hom.:
321
Cov.:
32
AF XY:
0.0540
AC XY:
4017
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.0152
AC:
632
AN:
41566
American (AMR)
AF:
0.0476
AC:
728
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0711
AC:
247
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5180
South Asian (SAS)
AF:
0.0201
AC:
97
AN:
4820
European-Finnish (FIN)
AF:
0.0560
AC:
594
AN:
10606
Middle Eastern (MID)
AF:
0.0582
AC:
17
AN:
292
European-Non Finnish (NFE)
AF:
0.0866
AC:
5892
AN:
68008
Other (OTH)
AF:
0.0579
AC:
122
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
406
813
1219
1626
2032
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0702
Hom.:
641
Bravo
AF:
0.0531
Asia WGS
AF:
0.0140
AC:
47
AN:
3478
EpiCase
AF:
0.0828
EpiControl
AF:
0.0842

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 27, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 31731663) -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Upshaw-Schulman syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.9
DANN
Benign
0.72
PhyloP100
-4.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28571612; hg19: chr9-136290672; COSMIC: COSV63020658; API